Armata Pharmaceuticals, Inc. — Director's Dealing 2017

Apr 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2017-04-01

Reporting Person: BILINSKY IGOR (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-01	Stock Option (Right to Buy)	$0.43	A	176411	Acquired	2021-03-31	Common Stock (176411)	Direct

Footnotes

F1: The shares subject to the option are 100% vested and exercisable as of the date of grant.